ロード中...
Analysis of the CDK4/6 Cell Cycle Pathway in Leiomyosarcomas as a Potential Target for Inhibition by Palbociclib
Leiomyosarcoma (LMS) is characterized by high genomic complexity, and to date, no specific targeted therapy is available. In a genome-wide approach, we profiled genomic aberrations in a small cohort of eight primary tumours, two relapses, and eight metastases across nine different patients. We ident...
保存先:
| 主要な著者: | , , , , , , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Hindawi Limited
2019-01-01
|
| シリーズ: | Sarcoma |
| オンライン･アクセス: | http://dx.doi.org/10.1155/2019/3914232 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|